[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU49138B - Protein derivative of human lipase stimulated by bile salt - Google Patents

Protein derivative of human lipase stimulated by bile salt

Info

Publication number
YU49138B
YU49138B YU95191A YU95191A YU49138B YU 49138 B YU49138 B YU 49138B YU 95191 A YU95191 A YU 95191A YU 95191 A YU95191 A YU 95191A YU 49138 B YU49138 B YU 49138B
Authority
YU
Yugoslavia
Prior art keywords
bile salt
protein derivative
human lipase
lipase stimulated
stimulated
Prior art date
Application number
YU95191A
Other languages
Serbo-Croatian (sh)
Other versions
YU95191A (en
Inventor
Gunnar Bjursell
Lars Bläckberg
Peter Carlsson
Sven Enerbäck
Olle Hernell
Jeanette Nilsson
Thomas Olivecrona
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Priority to HRP-951/91A priority Critical patent/HRP920771B1/en
Publication of YU95191A publication Critical patent/YU95191A/en
Publication of YU49138B publication Critical patent/YU49138B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Protein kao što je naznačen na slici VII od položaja 1 do položaja 722. Prijava sadrži još 4 nezavisna i 13 zavisnih zahteva.The protein as indicated in Figure VII from position 1 to position 722. The application contains 4 more independent and 13 dependent claims.

YU95191A 1990-06-01 1991-05-29 Protein derivative of human lipase stimulated by bile salt YU49138B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-951/91A HRP920771B1 (en) 1990-06-01 1992-10-01 New chemical products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (en) 1990-06-01 1990-06-01 NEW CHEMICAL PRODUCTS

Publications (2)

Publication Number Publication Date
YU95191A YU95191A (en) 1994-06-10
YU49138B true YU49138B (en) 2004-03-12

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
YU95191A YU49138B (en) 1990-06-01 1991-05-29 Protein derivative of human lipase stimulated by bile salt

Country Status (44)

Country Link
EP (1) EP0535048B1 (en)
JP (1) JPH05507201A (en)
KR (1) KR100212411B1 (en)
CN (2) CN1075113C (en)
AP (1) AP207A (en)
AT (1) ATE151077T1 (en)
AU (1) AU651979B2 (en)
BG (1) BG61165B1 (en)
CA (1) CA2083396C (en)
CZ (1) CZ287470B6 (en)
DE (1) DE69125489T2 (en)
DK (1) DK0535048T3 (en)
DZ (1) DZ1503A1 (en)
EG (1) EG19937A (en)
ES (1) ES2099159T3 (en)
FI (1) FI114639B (en)
GR (1) GR3023618T3 (en)
HK (1) HK62497A (en)
HR (1) HRP920771B1 (en)
HU (1) HU215258B (en)
IE (1) IE911844A1 (en)
IL (1) IL98273A (en)
IS (1) IS1751B (en)
JO (1) JO1694B1 (en)
LT (1) LT4020B (en)
LV (1) LV10292B (en)
MA (1) MA22166A1 (en)
MY (1) MY111245A (en)
NO (1) NO322962B1 (en)
NZ (1) NZ238223A (en)
PH (1) PH30761A (en)
PL (1) PL166534B1 (en)
PT (1) PT97836B (en)
RO (1) RO114793B1 (en)
RU (1) RU2140983C1 (en)
SE (1) SE9001985D0 (en)
SG (1) SG48078A1 (en)
SK (1) SK281089B6 (en)
TN (1) TNSN91041A1 (en)
TW (1) TW221712B (en)
UA (1) UA39165C2 (en)
WO (1) WO1991018923A1 (en)
YU (1) YU49138B (en)
ZA (1) ZA913778B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
IS4130A (en) * 1993-03-01 1994-09-02 Ab Astra New polypeptide
SE9300686D0 (en) 1993-03-01 1993-03-01 Astra Ab NOVEL POLYPEPTIDES
FR2754827B1 (en) * 1996-10-17 1998-12-24 Biocem PANCREATIC LIPASES AND / OR RECOMBINANT COLIPASES AND DERVIED POLYPEPTIDES PRODUCED BY PLANTS, PROCESSES FOR OBTAINING SAME AND USES THEREOF
JP2000026311A (en) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd Composition of gastric emptying ability accelerator
EP1963524A2 (en) * 2005-12-01 2008-09-03 University of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
BR112012027143B1 (en) 2010-04-23 2020-02-11 Synageva Biopharma Corp. GLYCOPROTEINS, ISOLATED HUMAN RECOMBINANT LISOSOMAL ACID LIPASE AND PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE SAME
JP5693728B2 (en) 2010-09-09 2015-04-01 シナジーバ バイオファーマ コープ Use of lysosomal acid lipase to treat lysosomal acid lipase deficiency in patients
DK2629790T3 (en) * 2010-10-21 2016-10-24 Swedish Orphan Biovitrum Ab (Publ) Approach to increase growth rate of human babies
WO2012052059A1 (en) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
KR20200018781A (en) 2017-06-19 2020-02-20 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) Fusion Proteins with Half-Life Extended Polypeptides
EP4022049A4 (en) 2019-08-30 2023-11-01 Codexis, Inc. Engineered lipase variants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000381A1 (en) * 1983-07-01 1985-01-31 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
JPH05507201A (en) 1993-10-21
PL166534B1 (en) 1995-05-31
AU651979B2 (en) 1994-08-11
DZ1503A1 (en) 2004-09-13
HRP920771A2 (en) 1997-04-30
ZA913778B (en) 1992-02-26
IL98273A (en) 2005-11-20
EG19937A (en) 2000-12-31
FI925453A (en) 1992-11-30
AU7964591A (en) 1991-12-31
GR3023618T3 (en) 1997-08-29
NZ238223A (en) 1993-05-26
HUT63184A (en) 1993-07-28
SG48078A1 (en) 1998-04-17
HU215258B (en) 1998-11-30
DK0535048T3 (en) 1997-09-29
ATE151077T1 (en) 1997-04-15
EP0535048A1 (en) 1993-04-07
RU2140983C1 (en) 1999-11-10
FI925453A0 (en) 1992-11-30
PT97836B (en) 1998-11-30
UA39165C2 (en) 2001-06-15
CA2083396A1 (en) 1991-12-02
NO322962B1 (en) 2006-12-18
KR100212411B1 (en) 1999-08-02
SE9001985D0 (en) 1990-06-01
AP9100270A0 (en) 1991-07-31
IS3710A7 (en) 1991-12-02
CA2083396C (en) 2006-09-19
IS1751B (en) 2000-07-21
HK62497A (en) 1997-05-16
BG97123A (en) 1993-12-24
TW221712B (en) 1994-03-11
AP207A (en) 1992-08-18
CN1326782A (en) 2001-12-19
MA22166A1 (en) 1991-12-31
MY111245A (en) 1999-10-30
LTIP1736A (en) 1995-08-25
PT97836A (en) 1992-02-28
DE69125489D1 (en) 1997-05-07
NO924528L (en) 1992-11-24
ES2099159T3 (en) 1997-05-16
SK281089B6 (en) 2000-11-07
HRP920771B1 (en) 1999-10-31
LT4020B (en) 1996-08-26
RO114793B1 (en) 1999-07-30
DE69125489T2 (en) 1997-08-14
WO1991018923A1 (en) 1991-12-12
EP0535048B1 (en) 1997-04-02
HU9203774D0 (en) 1993-03-29
LV10292A (en) 1994-10-20
FI114639B (en) 2004-11-30
CN1075113C (en) 2001-11-21
JO1694B1 (en) 1992-08-09
NO924528D0 (en) 1992-11-24
PH30761A (en) 1997-10-17
CN1064313A (en) 1992-09-09
BG61165B1 (en) 1997-01-31
IE911844A1 (en) 1991-12-04
TNSN91041A1 (en) 1992-10-25
IL98273A0 (en) 1992-06-21
LV10292B (en) 1995-08-20
CZ164491A3 (en) 1999-07-14
YU95191A (en) 1994-06-10
CZ287470B6 (en) 2000-12-13
SK164491A3 (en) 1995-07-11

Similar Documents

Publication Publication Date Title
ITMI920162A1 (en) METHOD TO MAINTAIN THE ACTIVITY OF PROTEOLYTIC ENZYMES MODIFIED WITH POLYETHYLENGLYCOL
ATE254443T1 (en) INHIBITING HAIR GROWTH
AT383428B (en) EYEGLASSES TO IMPROVE NATURAL HEARING
DK0714300T3 (en) Methods for regulating the sexual response in humans
LV11895A (en) Derivatives of 4-benzoylpyrazole and their use as herbicides
IT1171305B (en) PROCEDURE AND COMPOSITION TO ELIMINATE THE SMELL OF AMMONIA FROM ORGANIC WASTE
DE69637669D1 (en) MYOGENE DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
MX9405383A (en) IMIDAZO (4,5-C) PIRIDIN-4-AMINAS.
IT9067125A0 (en) HEART VALVE PROSTHESIS
DE69117333D1 (en) Display control unit to reduce power consumption
DE3484997D1 (en) CELL-stimulating agent.
YU49138B (en) Protein derivative of human lipase stimulated by bile salt
DK501389A (en) Hearing aid with organs to suppress unwanted feedback
ES2016920A4 (en) PROCEDURE FOR THE PRODUCTION OF ANTI-TORSION BARS BY IN SITU GLUING OF ELASTIC BEARINGS AND ANTI-TORSION BARS PERFORMED ACCORDING TO THE PROCEDURE.
IT1124579B (en) METHOD AND COMPLEX FOR THE ADAPTATION OF ACOUSTIC PROSTHESES
FR2495635B1 (en) HUMAN UROKINASE PRODUCTION
FR2626780B1 (en) DOLL SIMULATING HAIR GROWTH
ATE210989T1 (en) COMPOSITION AND METHOD FOR STIMULATING REPRODUCTIVE POWER
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
IT7824578A0 (en) PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF STATES OF FRIGIDITY AND IMPOTENCE.
BR9100445A (en) STABLE COMPOSITION OF WATER PESTICIDE DISPERSION
IT1177597B (en) ESTER OF HYDROXIDE OF TRICICLOE-SILSTAGNO ACARICIDE
IT8049317A0 (en) IMPROVEMENT IN HEART VALVE PROSTHESES
FI102621B1 (en) Use of copper-aluminum-zinc alloy as corrosion-resistant material
KR940009040U (en) Native beehives capable of natural distribution